Amoy Diagnostics Co Ltd

Overview

Amoy Diagnostics Co Ltd (AmoyDx) is a developer of molecular diagnostics for oncology precision medicine. The company provides gene mutation products such as mutation detection kit and gene fusions detection kit. It offers nucleic acid extraction products including DNA and RNA extraction kits. AmoyDx also provides super-ARMS EGFR mutation detection kit, HER-2 gene amplification analysis kit, HPV detection kit, human papillomavirus genotyping detection kit, and high-risk human papillomavirus detection kit. The company’s products are used for the treatment and diagnostics of lung cancer, colon cancer, and leukemia. It serves domestic and international oncology sector. The company markets its products through a network of distributors in Argentina, Iceland, Norway, Sweden, Switzerland and Belgium. AmoyDx is headquartered in Xiamen, China.
Key Stats
Address
No.39, Dingshan Road, Haicang District, Haicang District, XIAMEN, Fujian
Headquarters

China

Contact

86 592 6806830

Website
www.amoydx.com
No of Employees

840

Industry

Medical Equipment

Ticker Symbol & Exchange​

300685 [SZSE]

Revenue (2020)

$106 m

26.6% (2020 vs 2019)
Net Income (2020)

$26 m

32.6% (2020 vs 2019)
Net Profit Margin

25 %

5.7% (2020 vs 2019)
Market Cap *

$2,570 m

EPS *

$0.1

  *Note: Ratios based on the share price as of 8-September-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters Amoy Diagnostics Co LtdShanghai Kehua Bio-engineering Co LtdDirui Industrial Co LtdBeijing Strong Biotechnologies Inc
Key Information
Headquarters China China China China
Headquarter City XIAMEN SHANGHAI CHANGCHUN BEIJING
Headquarter State/Province Fujian Shanghai Jilin Beijing
No. of Employees 840 1,922 1,584 907
Entity Type Public Public Public Public

Products & Services

AmoyDx offers molecular diagnostics for oncology precision medicine. Key products offered by the company include the following:

Products
  • Products
  • Gene Mutation:
  • Mutation Detection Kit
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
Key Financial Charts
Sales Growth
Operating Margin
Net Income Growth
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets

Employees

Name Position Board Since Age Biography
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.

History

Year Event Description
2020 Contracts/Agreements In March, the company and Janssen (China) Research & Development Center signed an agreement to…
2020 Contracts/Agreements In August, the company and Merck KGaA signed an agreement to develop companion diagnostics for…
2019 Contracts/Agreements In November, the company entered into a diagnostic partnership agreement with Eisai to develop and…
2008 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam

Locations


AmoyDx (Canada) Ltd
Xiamen Deming Medical Technology Co., Ltd.
Beijing Xiawei Technical Service Co., Ltd.
Shanghai Xiawei Biotechnology Co., Ltd.
Shanghai Xiawei Medical Inspection Laboratory Co., Ltd.
Xiamen Aide Biotechnology Research Center Co., Ltd.
AmoyDx (SINGAPORE) PTE. LTD
AmoyDx (HONGKONG) Ltd.

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target